Dopavision

Dopavision is a company that develops a digital therapeutic for myopia, which can be invisibly integrated with the use of a smartphone. Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself. Dopavision's technology delivers light stimulation to specific photosensitive cells on the retina, which modulate dopamine, a neurotransmitter that is important for the regulation of eye growth.